The Middle East and Africa cancer hormone therapy market is expanding due to rising cancer incidence and increasing adoption of advanced oncology treatments across the region. The Middle East and Africa cancer hormone therapy market is estimated to record a CAGR of 8.3% from 2025 to 2031. The demand for cancer hormone therapy in the Middle East and Africa is being driven primarily by the...